首页 > 最新文献

Endocrinologia Diabetes Y Nutricion最新文献

英文 中文
Beyond vectorial bioelectrical impedance: Assessing body composition changes with novel electrical parameters in obese osteoarthritis patients on a meal-replacement diet 超越矢量生物电阻抗:用新的电参数评估肥胖骨关节炎患者在代餐饮食中的身体成分变化
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-01 DOI: 10.1016/j.endien.2025.501644
José-Joaquín Alfaro-Martínez , David Primo-Martín , César Gonzalvo-Díaz , Olatz Izaola-Jauregui , Marina Jara-Vidal , Lourdes García-Blasco , Beatriz Ramos-Bachiller , Diego Bellido-Guerrero , Daniel A. De Luis-Román , Juan José López-Gómez

Background

Rapid weight loss with restricted diets can cause muscle mass decline. The aim of this work is to evaluate a new method for representing the raw electrical values obtained in the bioelectrical impedance analysis (BIA) in patients with obesity and osteoarthritis undergoing a meal-replacement diet.

Methods

We conducted a 1-group intervention study with meal-replacement diet for 3 months in patients with osteoarthritis prior to orthopedic surgery. Anthropometry and BIA was registered at baseline (B) and 3 months (3M) after the intervention. We have calculated traditional estimations of body composition over the raw electrical parameters of BIA parameters and a new bioelectrical impedance vector analysis (BIVA) based method to detect nutrition (NP), hydration (HP) and fat (FP) parameters without estimation.

Results

A total of 272 patients (23.16% men; 76.84% women) were analyzed. There was a correlation between NP and body composition estimates (body cell mass [BCM] standardized by height (BCM/h): men: 0.96; p < 0.01; women: 0.88; p < 0.01). The correlation coefficient between HP and estimated total body water was 0.769 for men and 0.63 for women (p < 0.01 in both cases). The correlation coefficient between FP and estimated fat mass (FM) standardized by height was 0.83 for men and 0.89 for women (p < 0.01). There was a significant decrease in body weight (B: 99.33(15.0) kg; 3M: 92.03(16.0) kg; p < 0.01); and FM (B: 49.93(6.67) kg; 3M: 44.22(9.08) kg). There was no difference in BCM and fat free mass. In new parameters a decrease in NP (B: +0.50(0.31); 3M: +0.42(0.42); p = 0.03) and FP (B: +0.49(0.17) was reported; 3M: +0.38(0.16); p < 0.01), although there was no difference in HP.

Conclusions

The new interpretation of BIVA as NP and HP have a high correlation with the body composition parameters estimated by regression models, and they report changes in body composition after a partial meal-replacement diet such as regression equations.
背景:限制饮食的快速减肥会导致肌肉质量下降。这项工作的目的是评估一种新的方法来表示在进行代餐饮食的肥胖和骨关节炎患者的生物电阻抗分析(BIA)中获得的原始电值。方法对骨科手术前骨关节炎患者进行为期3个月的代餐饮食干预研究。在基线(B)和干预后3个月(3M)记录人体测量和BIA。我们计算了基于BIA参数的原始电参数的传统身体成分估计值,以及一种新的基于生物电阻抗矢量分析(BIVA)的检测营养(NP)、水合(HP)和脂肪(FP)参数的方法。结果共分析272例患者,其中男性23.16%,女性76.84%。NP与身体成分估计值(身高标准化的体细胞质量[BCM] (BCM/h))之间存在相关性:男性:0.96;p < 0.01;女性:0.88;p < 0.01)。HP与估计的总体内水分之间的相关系数男性为0.769,女性为0.63(两种情况的p <; 0.01)。男性的FP与身高标准化的估计脂肪量(FM)的相关系数为0.83,女性为0.89 (p < 0.01)。体重显著下降(B: 99.33(15.0) kg;3M: 92.03(16.0) kg;p < 0.01);FM (B): 49.93(6.67) kg;3米:44.22(9.08)公斤。BCM和无脂质量无显著差异。在新参数下,NP (B)降低:+0.50(0.31);3 m: + 0.42 (0.42);p = 0.03)和FP (B: +0.49(0.17));3 m: + 0.38 (0.16);p < 0.01),但HP无差异。结论BIVA的新解释为NP和HP与回归模型估计的体成分参数具有高度相关性,它们报告了部分代餐饮食后体成分的变化,如回归方程。
{"title":"Beyond vectorial bioelectrical impedance: Assessing body composition changes with novel electrical parameters in obese osteoarthritis patients on a meal-replacement diet","authors":"José-Joaquín Alfaro-Martínez ,&nbsp;David Primo-Martín ,&nbsp;César Gonzalvo-Díaz ,&nbsp;Olatz Izaola-Jauregui ,&nbsp;Marina Jara-Vidal ,&nbsp;Lourdes García-Blasco ,&nbsp;Beatriz Ramos-Bachiller ,&nbsp;Diego Bellido-Guerrero ,&nbsp;Daniel A. De Luis-Román ,&nbsp;Juan José López-Gómez","doi":"10.1016/j.endien.2025.501644","DOIUrl":"10.1016/j.endien.2025.501644","url":null,"abstract":"<div><h3>Background</h3><div>Rapid weight loss with restricted diets can cause muscle mass decline. The aim of this work is to evaluate a new method for representing the raw electrical values obtained in the bioelectrical impedance analysis (BIA) in patients with obesity and osteoarthritis undergoing a meal-replacement diet.</div></div><div><h3>Methods</h3><div>We conducted a 1-group intervention study with meal-replacement diet for 3 months in patients with osteoarthritis prior to orthopedic surgery. Anthropometry and BIA was registered at baseline (B) and 3 months (3M) after the intervention. We have calculated traditional estimations of body composition over the raw electrical parameters of BIA parameters and a new bioelectrical impedance vector analysis (BIVA) based method to detect nutrition (NP), hydration (HP) and fat (FP) parameters without estimation.</div></div><div><h3>Results</h3><div>A total of 272 patients (23.16% men; 76.84% women) were analyzed. There was a correlation between NP and body composition estimates (body cell mass [BCM] standardized by height (BCM/h): men: 0.96; <em>p</em> <!-->&lt;<!--> <!-->0.01; women: 0.88; <em>p</em> <!-->&lt;<!--> <!-->0.01). The correlation coefficient between HP and estimated total body water was 0.769 for men and 0.63 for women (<em>p</em> <!-->&lt;<!--> <!-->0.01 in both cases). The correlation coefficient between FP and estimated fat mass (FM) standardized by height was 0.83 for men and 0.89 for women (<em>p</em> <!-->&lt;<!--> <!-->0.01). There was a significant decrease in body weight (<em>B</em>: 99.33(15.0)<!--> <!-->kg; 3M: 92.03(16.0)<!--> <!-->kg; <em>p</em> <!-->&lt;<!--> <!-->0.01); and FM (<em>B</em>: 49.93(6.67)<!--> <!-->kg; 3M: 44.22(9.08)<!--> <!-->kg). There was no difference in BCM and fat free mass. In new parameters a decrease in NP (<em>B</em>: +0.50(0.31); 3M: +0.42(0.42); <em>p</em> <!-->=<!--> <!-->0.03) and FP (<em>B</em>: +0.49(0.17) was reported; 3M: +0.38(0.16); <em>p</em> <!-->&lt;<!--> <!-->0.01), although there was no difference in HP.</div></div><div><h3>Conclusions</h3><div>The new interpretation of BIVA as NP and HP have a high correlation with the body composition parameters estimated by regression models, and they report changes in body composition after a partial meal-replacement diet such as regression equations.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"73 1","pages":"Article 501644"},"PeriodicalIF":1.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146001833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radioactive iodine-induced esophagitis: A rare complication 放射性碘引起的食管炎:一种罕见的并发症
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-01 DOI: 10.1016/j.endien.2025.501656
Ignacio Jiménez Hernando , Irene Bretón Lesmes , Arantxa Díaz Gómez , Miguel Sebastián Casallas Cepeda , Santiago Salcedo Cortés
{"title":"Radioactive iodine-induced esophagitis: A rare complication","authors":"Ignacio Jiménez Hernando ,&nbsp;Irene Bretón Lesmes ,&nbsp;Arantxa Díaz Gómez ,&nbsp;Miguel Sebastián Casallas Cepeda ,&nbsp;Santiago Salcedo Cortés","doi":"10.1016/j.endien.2025.501656","DOIUrl":"10.1016/j.endien.2025.501656","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"73 1","pages":"Article 501656"},"PeriodicalIF":1.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146001818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin K in home parenteral nutrition: Is it really necessary? 家庭肠外营养中的维生素K:真的有必要吗?
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-01 DOI: 10.1016/j.endien.2025.501655
Estrella Diego , María del Carmen Farnández , Beatriz de León , Andoni Monzón , Leire Isasa , Beatriz Sordo , Nuria Valdés

Introduction

Multivitamin preparations with added vitamin K in parenteral nutrition (PN) ensure the coverage of this micronutrient in all adults, as indicated by the latest ESPEN clinical practice guidelines on micronutrients.

Objectives

To monitor vitamin K levels after adding this multivitamin with vitamin K in patients requiring home parenteral nutrition (HPN) at Hospital Universitario Cruces (Bilbao, Basque County, Spain) from 2021 to 2022.

Materials and methods

We analyzed vitamin K levels were collected 6 months into therapy with the multivitamin containing vitamin K in home parenteral nutrition.

Results

At our centre, a total of 8 patients required home parenteral nutrition due to intestinal failure type III, 60% of whom were men, with a mean age of 58 ± 13 years. The cause of intestinal failure was short bowel syndrome (50%), intestinal mucosal disease (38%), and intestinal dysmotility (12%). After adding the multivitamin with vitamin K, 80% (6/8) of patients exhibited elevated vitamin K levels, with a mean of 4.4 μl/L.

Conclusions

After observing vitamin K levels above the upper limit of normal, we reached consensus with the Pharmacy Service to discontinue this multivitamin and restart conventional multivitamin. After this initiative, the vitamin K levels of our patients normalized.
根据最新的ESPEN微量营养素临床实践指南,在肠外营养(PN)中添加维生素K的多种维生素制剂可确保所有成年人都能获得这种微量营养素。目的监测2021年至2022年在西班牙巴斯克县毕尔巴鄂大学医院(Universitario Cruces)需要家庭肠外营养(HPN)的患者添加该复合维生素和维生素K后的维生素K水平。材料与方法采用含维生素K复合维生素的家庭肠外营养治疗6个月后收集患者的维生素K水平。结果本中心共有8例III型肠衰竭患者需要家庭肠外营养,其中60%为男性,平均年龄58±13岁。肠衰竭的原因是短肠综合征(50%)、肠黏膜疾病(38%)和肠蠕动障碍(12%)。加维生素K复合维生素后,80%(6/8)的患者维生素K水平升高,平均为4.4 μl/L。结论在观察到维生素K水平超过正常上限后,我们与药房达成共识,停止使用该复合维生素,重新使用常规复合维生素。这一举措后,我们的病人的维生素K水平恢复正常。
{"title":"Vitamin K in home parenteral nutrition: Is it really necessary?","authors":"Estrella Diego ,&nbsp;María del Carmen Farnández ,&nbsp;Beatriz de León ,&nbsp;Andoni Monzón ,&nbsp;Leire Isasa ,&nbsp;Beatriz Sordo ,&nbsp;Nuria Valdés","doi":"10.1016/j.endien.2025.501655","DOIUrl":"10.1016/j.endien.2025.501655","url":null,"abstract":"<div><h3>Introduction</h3><div>Multivitamin preparations with added vitamin K in parenteral nutrition (PN) ensure the coverage of this micronutrient in all adults, as indicated by the latest ESPEN clinical practice guidelines on micronutrients.</div></div><div><h3>Objectives</h3><div>To monitor vitamin K levels after adding this multivitamin with vitamin K in patients requiring home parenteral nutrition (HPN) at <em>Hospital Universitario Cruces</em> (Bilbao, Basque County, Spain) from 2021 to 2022.</div></div><div><h3>Materials and methods</h3><div>We analyzed vitamin K levels were collected 6 months into therapy with the multivitamin containing vitamin K in home parenteral nutrition.</div></div><div><h3>Results</h3><div>At our centre, a total of 8 patients required home parenteral nutrition due to intestinal failure type III, 60% of whom were men, with a mean age of 58<!--> <!-->±<!--> <!-->13 years. The cause of intestinal failure was short bowel syndrome (50%), intestinal mucosal disease (38%), and intestinal dysmotility (12%). After adding the multivitamin with vitamin K, 80% (6/8) of patients exhibited elevated vitamin K levels, with a mean of 4.4<!--> <!-->μl/L.</div></div><div><h3>Conclusions</h3><div>After observing vitamin K levels above the upper limit of normal, we reached consensus with the Pharmacy Service to discontinue this multivitamin and restart conventional multivitamin. After this initiative, the vitamin K levels of our patients normalized.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"73 1","pages":"Article 501655"},"PeriodicalIF":1.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146001834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in pituitary tumors following the 2022 WHO classification 2022年世卫组织分类后垂体肿瘤的最新进展
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-01 DOI: 10.1016/j.endien.2026.501747
Ignacio Ruz-Caracuel
{"title":"Recent advances in pituitary tumors following the 2022 WHO classification","authors":"Ignacio Ruz-Caracuel","doi":"10.1016/j.endien.2026.501747","DOIUrl":"10.1016/j.endien.2026.501747","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"73 1","pages":"Article 501747"},"PeriodicalIF":1.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146001832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute pancreatitis in an infant, a rare diagnosis 婴儿急性胰腺炎,罕见的诊断。
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2026-01-01 DOI: 10.1016/j.endien.2025.501660
Fátima Pareja Marín, María Pilar Valverde Viu, Sara Vicent Martí, Violeta Martí Enrique
{"title":"Acute pancreatitis in an infant, a rare diagnosis","authors":"Fátima Pareja Marín,&nbsp;María Pilar Valverde Viu,&nbsp;Sara Vicent Martí,&nbsp;Violeta Martí Enrique","doi":"10.1016/j.endien.2025.501660","DOIUrl":"10.1016/j.endien.2025.501660","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"73 1","pages":"Article 501660"},"PeriodicalIF":1.8,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ovarian metastasis in a young woman with follicular thyroid carcinoma: A differential diagnosis with struma ovarii. 年轻女性滤泡性甲状腺癌的卵巢转移:与卵巢甲状腺肿的鉴别诊断。
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-13 DOI: 10.1016/j.endien.2025.501676
Dolores Tejedo-Flors, Thalía Argüello-Gordillo, Elena Argente-Martínez, Beatriz López-Muñoz, Pedro López-Mondéjar
{"title":"Ovarian metastasis in a young woman with follicular thyroid carcinoma: A differential diagnosis with struma ovarii.","authors":"Dolores Tejedo-Flors, Thalía Argüello-Gordillo, Elena Argente-Martínez, Beatriz López-Muñoz, Pedro López-Mondéjar","doi":"10.1016/j.endien.2025.501676","DOIUrl":"https://doi.org/10.1016/j.endien.2025.501676","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":"501676"},"PeriodicalIF":1.8,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second edition of the "do not do" recommendations from the Spanish Society of Endocrinology and Nutrition (SEEN). 西班牙内分泌与营养学会(SEEN)的第二版“不做”建议。
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-13 DOI: 10.1016/j.endien.2025.501687
Juan José Díez, Manuel Gargallo Fernández, José Antonio Gimeno Orna, Elena González Arnaiz, Isabel Huguet Moreno, Sílvia Martínez Couselo, María Miguélez González, María Julia Ocón, Gilberto Pérez López, Francisco Pita Gutiérrez, Jordi Luis Reverter Calatayud, Cristina Tejera Pérez, Eulàlia Urgell Rull, Alberto Fernández

Low-value clinical practices - defined as diagnostic or therapeutic interventions that provide limited clinical benefit and may be associated with unnecessary risks or costs - remain common in endocrinology and nutrition. The Spanish Society of Endocrinology and Nutrition (SEEN) presents this second edition as an updated set of recommendations on "what not to do" in clinical practice, developed by its sections and working groups. The methodological process included the selection of relevant topics, systematic literature review, and multidisciplinary consensus. Key areas addressed include diabetes, obesity, nutrition, gonads, lipids, laboratory, mineral metabolism, and imaging, identifying low-value interventions and offering alternatives based on the best available evidence. The implementation of these recommendations aims to optimize care quality, reduce risks, and contribute to the sustainability of the healthcare system.

低价值临床实践-定义为提供有限临床效益的诊断或治疗干预,可能与不必要的风险或成本相关-在内分泌学和营养学中仍然很常见。西班牙内分泌与营养学会(SEEN)将第二版作为一套更新的关于临床实践中“不该做什么”的建议,由其部门和工作组开发。方法学过程包括选择相关主题、系统文献综述和多学科共识。涉及的关键领域包括糖尿病、肥胖、营养、性腺、脂质、实验室、矿物质代谢和成像,识别低价值干预措施,并根据现有的最佳证据提供替代方案。这些建议的实施旨在优化护理质量,降低风险,并有助于卫生保健系统的可持续性。
{"title":"Second edition of the \"do not do\" recommendations from the Spanish Society of Endocrinology and Nutrition (SEEN).","authors":"Juan José Díez, Manuel Gargallo Fernández, José Antonio Gimeno Orna, Elena González Arnaiz, Isabel Huguet Moreno, Sílvia Martínez Couselo, María Miguélez González, María Julia Ocón, Gilberto Pérez López, Francisco Pita Gutiérrez, Jordi Luis Reverter Calatayud, Cristina Tejera Pérez, Eulàlia Urgell Rull, Alberto Fernández","doi":"10.1016/j.endien.2025.501687","DOIUrl":"https://doi.org/10.1016/j.endien.2025.501687","url":null,"abstract":"<p><p>Low-value clinical practices - defined as diagnostic or therapeutic interventions that provide limited clinical benefit and may be associated with unnecessary risks or costs - remain common in endocrinology and nutrition. The Spanish Society of Endocrinology and Nutrition (SEEN) presents this second edition as an updated set of recommendations on \"what not to do\" in clinical practice, developed by its sections and working groups. The methodological process included the selection of relevant topics, systematic literature review, and multidisciplinary consensus. Key areas addressed include diabetes, obesity, nutrition, gonads, lipids, laboratory, mineral metabolism, and imaging, identifying low-value interventions and offering alternatives based on the best available evidence. The implementation of these recommendations aims to optimize care quality, reduce risks, and contribute to the sustainability of the healthcare system.</p>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":"501687"},"PeriodicalIF":1.8,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence, incidence, and occupational risk markers of dyslipidemia in Peruvian workers. 秘鲁工人血脂异常的患病率、发病率和职业危险标志。
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-04 DOI: 10.1016/j.endien.2025.501672
Jhosmer Ballena-Caicedo, Fiorella E Zuzunaga-Montoya, Juan Carlos Bustamante-Rodríguez, Nataly Mayely Sanchez-Tamay, Luisa Erika Milagros Vásquez-Romero, Joan A Loayza-Castro, Carmen Inés Gutierrez De Carrillo, Víctor Juan Vera-Ponce

Introduction: Dyslipidemias are a significant risk factor for cardiovascular diseases. In Peru, nutritional transition and lifestyle changes may be contributing to an increase in the incidence of these metabolic disorders, particularly among the working population.

Objective: To determine the incidence of dyslipidemias and evaluate associated occupational factors in Peruvian workers.

Methods: A retrospective cohort study was conducted using electronic medical records from 4,200 workers attending an occupational health clinic between 2013 and 2022. Incidence rates of hypertriglyceridemia, hypercholesterolemia, and combined dyslipidemia were calculated. Specific occupational factors (type of work, sitting time, and night shift work) were analyzed using Cox regression models adjusted for age (with splines) and sex.

Results: The incidence of hypercholesterolemia (87.22 cases per 1,000 person-years; 95% CI: 79.99-94.45) was significantly higher than that of hypertriglyceridemia (65.71 cases per 1,000 person-years; 95% CI: 59.71-71.72). Combined dyslipidemia showed an incidence of 48.28 cases per 1,000 person-years (95% CI: 43.60-52.97). Workers in social services had a higher risk of developing dyslipidemias (aHR: 1.78; 95% CI: 1.27-2.49) compared to office workers. Prolonged sitting time (>4 h) was significantly associated with an increased risk of hypertriglyceridemia (aHR: 1.28; 95% CI: 1.05-1.56) and combined dyslipidemia (aHR: 1.42; 95% CI: 1.15-1.76).

Conclusions: The high incidence of dyslipidemias-particularly hypercholesterolemia-may reflect the increasing consumption of ultra-processed foods and the ongoing nutritional transition in the Peruvian population. Occupational factors play a crucial role in the development of these metabolic disorders, highlighting the need for specific preventive strategies in the workplace.

简介:血脂异常是心血管疾病的重要危险因素。在秘鲁,营养的转变和生活方式的改变可能导致这些代谢紊乱的发病率增加,特别是在劳动人口中。目的:了解秘鲁工人血脂异常的发病率及相关职业因素。方法:对2013年至2022年期间在一家职业健康诊所就诊的4200名工人的电子病历进行回顾性队列研究。计算高甘油三酯血症、高胆固醇血症和合并血脂异常的发生率。具体职业因素(工作类型、坐着时间和夜班工作)使用Cox回归模型进行分析,调整年龄(样条)和性别。结果:高胆固醇血症发生率(87.22例/ 1000人年,95% CI: 79.99 ~ 94.45)显著高于高甘油三酯血症发生率(65.71例/ 1000人年,95% CI: 59.71 ~ 71.72)。合并血脂异常的发生率为每1000人年48.28例(95% CI: 43.60-52.97)。与办公室工作人员相比,社会服务工作者患血脂异常的风险更高(aHR: 1.78; 95% CI: 1.27-2.49)。长时间坐着(bbbb4小时)与高甘油三酯血症(aHR: 1.28; 95% CI: 1.05-1.56)和合并血脂异常(aHR: 1.42; 95% CI: 1.15-1.76)的风险增加显著相关。结论:高发的血脂异常-特别是高胆固醇血症-可能反映了秘鲁人口中超加工食品消费的增加和正在进行的营养转变。职业因素在这些代谢紊乱的发展中起着至关重要的作用,强调需要在工作场所采取具体的预防策略。
{"title":"Prevalence, incidence, and occupational risk markers of dyslipidemia in Peruvian workers.","authors":"Jhosmer Ballena-Caicedo, Fiorella E Zuzunaga-Montoya, Juan Carlos Bustamante-Rodríguez, Nataly Mayely Sanchez-Tamay, Luisa Erika Milagros Vásquez-Romero, Joan A Loayza-Castro, Carmen Inés Gutierrez De Carrillo, Víctor Juan Vera-Ponce","doi":"10.1016/j.endien.2025.501672","DOIUrl":"https://doi.org/10.1016/j.endien.2025.501672","url":null,"abstract":"<p><strong>Introduction: </strong>Dyslipidemias are a significant risk factor for cardiovascular diseases. In Peru, nutritional transition and lifestyle changes may be contributing to an increase in the incidence of these metabolic disorders, particularly among the working population.</p><p><strong>Objective: </strong>To determine the incidence of dyslipidemias and evaluate associated occupational factors in Peruvian workers.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted using electronic medical records from 4,200 workers attending an occupational health clinic between 2013 and 2022. Incidence rates of hypertriglyceridemia, hypercholesterolemia, and combined dyslipidemia were calculated. Specific occupational factors (type of work, sitting time, and night shift work) were analyzed using Cox regression models adjusted for age (with splines) and sex.</p><p><strong>Results: </strong>The incidence of hypercholesterolemia (87.22 cases per 1,000 person-years; 95% CI: 79.99-94.45) was significantly higher than that of hypertriglyceridemia (65.71 cases per 1,000 person-years; 95% CI: 59.71-71.72). Combined dyslipidemia showed an incidence of 48.28 cases per 1,000 person-years (95% CI: 43.60-52.97). Workers in social services had a higher risk of developing dyslipidemias (aHR: 1.78; 95% CI: 1.27-2.49) compared to office workers. Prolonged sitting time (>4 h) was significantly associated with an increased risk of hypertriglyceridemia (aHR: 1.28; 95% CI: 1.05-1.56) and combined dyslipidemia (aHR: 1.42; 95% CI: 1.15-1.76).</p><p><strong>Conclusions: </strong>The high incidence of dyslipidemias-particularly hypercholesterolemia-may reflect the increasing consumption of ultra-processed foods and the ongoing nutritional transition in the Peruvian population. Occupational factors play a crucial role in the development of these metabolic disorders, highlighting the need for specific preventive strategies in the workplace.</p>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":"501672"},"PeriodicalIF":1.8,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial hypogonadotropic hypogonadism: The convergence of two genetic defects. 家族性促性腺功能减退症:两种遗传缺陷的汇合。
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-04 DOI: 10.1016/j.endien.2025.501675
Luis Muñoz Arenas, Mercedes Senent Capote, Javier Olmedo Pérez-Montaut, Antonio Ballesteros Martín-Portugués, Esteban Sánchez-Toscano, Maria Gloria Baena-Nieto
{"title":"Familial hypogonadotropic hypogonadism: The convergence of two genetic defects.","authors":"Luis Muñoz Arenas, Mercedes Senent Capote, Javier Olmedo Pérez-Montaut, Antonio Ballesteros Martín-Portugués, Esteban Sánchez-Toscano, Maria Gloria Baena-Nieto","doi":"10.1016/j.endien.2025.501675","DOIUrl":"https://doi.org/10.1016/j.endien.2025.501675","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":"501675"},"PeriodicalIF":1.8,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Executive summary of the consensus document for the management of severe Cushing's syndrome: Consensus document of the Neuroendocrinology Focus Group of the Spanish Society of Endocrinology and Nutrition (SEEN) 严重库欣综合征治疗共识文件执行摘要:西班牙内分泌与营养学会(SEEN)神经内分泌焦点小组共识文件
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-01 DOI: 10.1016/j.endien.2025.501654
Marta Araujo-Castro , Rogelio García-Centeno , Javier Aller , Mónica Marazuela , Alfonso Soto , María Ángeles Gálvez , Rosa Cámara , Elena Valassi , Ignacio Bernabeu , Rocío Villar-Taibo , Felicia A. Hanzu
Severe Cushing's syndrome (SCS) is usually defined as a CS with urinary free cortisol (UFC) levels above five times the upper limit of normal or associated with severe complications of hypercortisolism. Combination therapy with ketoconazole and metyrapone is a useful option for these patients. Osilodrostat is the most potent and effective oral drug in monotherapy for the treatment of SCS. For cases with very severe hypercortisolism and/or oral intolerance, etomidate is the most effective and rapid drug for reducing cortisol levels. Bilateral adrenalectomy may be indicated in cases of life-threatening severe hypercortisolism, but UFC should be reduced before surgery to reduce the perioperative morbimortality. Prompt treatment of comorbidities and thrombo- and infection prophylaxis are recommended. In conclusion, a rapid control of hypercortisolism is vital in SCS, and for this purpose combination therapy or potent drugs with a rapid onset of action such as etomidate or osilodrostat are indicated.
严重库欣综合征(SCS)通常定义为尿游离皮质醇(UFC)水平高于正常上限5倍或伴有严重高皮质醇症并发症的CS。酮康唑和美替拉酮联合治疗对这些患者是一个有用的选择。奥西洛他是单药治疗SCS最有效的口服药物。对于非常严重的高皮质醇血症和/或口服不耐受的病例,依托咪酯是降低皮质醇水平最有效和最快速的药物。在危及生命的严重高皮质醇血症病例中,可能需要双侧肾上腺切除术,但术前应减少UFC,以降低围手术期的死亡率。建议及时治疗合并症,预防血栓和感染。总之,快速控制高皮质醇血症对SCS至关重要,为此需要联合治疗或快速起效的强效药物,如依托咪酯或奥西洛他。
{"title":"Executive summary of the consensus document for the management of severe Cushing's syndrome: Consensus document of the Neuroendocrinology Focus Group of the Spanish Society of Endocrinology and Nutrition (SEEN)","authors":"Marta Araujo-Castro ,&nbsp;Rogelio García-Centeno ,&nbsp;Javier Aller ,&nbsp;Mónica Marazuela ,&nbsp;Alfonso Soto ,&nbsp;María Ángeles Gálvez ,&nbsp;Rosa Cámara ,&nbsp;Elena Valassi ,&nbsp;Ignacio Bernabeu ,&nbsp;Rocío Villar-Taibo ,&nbsp;Felicia A. Hanzu","doi":"10.1016/j.endien.2025.501654","DOIUrl":"10.1016/j.endien.2025.501654","url":null,"abstract":"<div><div>Severe Cushing's syndrome (SCS) is usually defined as a CS with urinary free cortisol (UFC) levels above five times the upper limit of normal or associated with severe complications of hypercortisolism. Combination therapy with ketoconazole and metyrapone is a useful option for these patients. Osilodrostat is the most potent and effective oral drug in monotherapy for the treatment of SCS. For cases with very severe hypercortisolism and/or oral intolerance, etomidate is the most effective and rapid drug for reducing cortisol levels. Bilateral adrenalectomy may be indicated in cases of life-threatening severe hypercortisolism, but UFC should be reduced before surgery to reduce the perioperative morbimortality. Prompt treatment of comorbidities and thrombo- and infection prophylaxis are recommended. In conclusion, a rapid control of hypercortisolism is vital in SCS, and for this purpose combination therapy or potent drugs with a rapid onset of action such as etomidate or osilodrostat are indicated.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 10","pages":"Article 501654"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145766125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrinologia Diabetes Y Nutricion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1